Medexus Pharmaceuticals Reports Operating and Financial Results for the First Quarter of Fiscal 2020

NEXT STORY
Chi-Med Initiates a Phase I Trial of HMPL-523 in Patients with Immune Thrombocytopenia (ITP) in China
PREV STORY
Tempus Expands Leadership Team With the Appointment of Joel Dudley, PhD, as Senior Vice President of Research
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BriaCell to Attend 20th Annual BIO CEO & Investor Conference

BERKELEY, Calif. and VANCOUVER, British Columbia, Feb. 07, 2018 (GLOBE NEWSWIRE) -- BriaCell Therapeutics ...

author_avatar
NASDAQ Market News

Two-year data for Novartis brolucizumab reaffirm superiority versus aflibercept in reducing retinal fluid in patients with nAMD

Year two results consistent with previously announced key secondary endpoint data on retinal fluid ...

author_avatar
NASDAQ Market News

genedrive to premier its Genedrive® Hepatitis C test in Asia Pacific

3 April 2018 genedrive plc ("genedrive" or the "Company")    Genedrive® HCV ID Kit ...

author_avatar
NASDAQ Market News